HOTH - Hoth Therapeutics to provide an update on endocannabinoid therapeutic on May 18

Hoth Therapeutics (HOTH) plans to host a virtual information session on its pipeline product, HT-005 Z-Pods on Tuesday, May 18th at 11:00am ET for interested shareholders.HT-005 Z-Pods is a novel endocannibinoid treatment for patients with Cutaneous Lupus Erythematosus ((CLE)).Adam Friedman, MD, FAAD and Professor and Chair of Dermatology at George Washington School of Medicine and Health Sciences will provide an overview on how HT-005 Z-Pods is designed to address treatment and quality of life concerns for CLE patients and will also provide a brief overview of the proof-of-concept efficacy data from an animal study.  HOTH shares up 3% premarket trading at $1.37.

For further details see:

Hoth Therapeutics to provide an update on endocannabinoid therapeutic on May 18